ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

7.91
Delayed Data
As of Jul 02
 -0.18 / -2.22%
Today’s Change
4.90
Today|||52-Week Range
9.89
+15.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.5B

Company Description

ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. Its products includes Iclusig (ponatinib), Brigatinib (previously known as AP26113), and AP32788. The company was founded by Harvey J. Berger in April 1991 and is headquartered in Cambridge, MA.

Contact Information

ARIAD Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge Massachusetts 02139-4234
P:(617) 494-0400
Investor Relations:
(617) 503-7028

Employees

Shareholders

Other institutional46.34%
Mutual fund holders33.57%
Individual stakeholders10.55%

Top Executives

Harvey J. BergerChairman, President & Chief Executive Officer
Edward M. FitzgeraldChief Financial Officer, Treasurer & Executive VP
Timothy P. ClacksonChief Scientific Officer
Frank G. HaluskaChief Medical Officer
Nicholas VentrescaChief Information Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account